Behavioral interventions in patients with an implantable cardioverter defibrillator: lessons learned and where to go

Mirela Habibović1, Matthew M Burg, Susanne S Pedersen

  • 1CoRPS - Department of Medical and Clinical Psychology, Tilburg University, The Netherlands.

Insights

Behavioral interventions can reduce psychological distress in implantable cardioverter defibrillator (ICD) patients. Future research should focus on large, individualized trials rather than a one-size-fits-all approach.

Area of Science:

  • Cardiology
  • Psychology
  • Behavioral Science

Background:

  • Implantable cardioverter defibrillators (ICDs) are crucial for preventing sudden cardiac death.
  • Some patients experience significant psychological distress after ICD implantation.
  • Current evidence for addressing this distress is limited.

Purpose of the Study:

  • To critically review existing behavioral interventions for ICD patients.
  • To identify effective strategies for managing psychological distress.
  • To propose future research directions based on current trials.

Main Methods:

  • Systematic literature search of PubMed and PsycInfo databases.
  • Inclusion of behavioral trials targeting distress in ICD patients (1980-2012).
  • Analysis of 17 identified trials.

Main Results:

  • Behavioral interventions generally reduced anxiety and depression compared to usual care.
  • Effect sizes for anxiety and depression reduction ranged from small to large.
  • Limitations include small sample sizes and potential selection bias.

Conclusions:

  • Behavioral interventions show promise for reducing distress in ICD patients.
  • Larger, individualized intervention trials are needed.
  • A "one size fits all" approach is not suitable for all ICD patients.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...